Neffy Spray
NDC Package 82580-010-02
Package Information
Neffy (epinephrine) sprays is a medication used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. This formulation utilizes a spray delivery system. Marketed by Ars Pharmaceuticals Operations, Inc., this product is identified by NDC 82580-010 and is authorized under FDA application NDA214697.
Identification & Billing
- RxCUI: 2693442 - EPINEPHrine 2 MG in 0.1 ML Nasal Spray
- RxCUI: 2693442 - epinephrine 20 MG/ML Nasal Spray
- RxCUI: 2693442 - epinephrine 2 MG per 0.1 ML Nasal Spray
- RxCUI: 2693448 - neffy 2 MG in 0.1 ML Nasal Spray
- RxCUI: 2693448 - epinephrine 20 MG/ML Nasal Spray [Neffy]
Clinical Specifications
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 82580 - Ars Pharmaceuticals Operations, Inc.
- 82580-010 - Neffy
- 82580-010-02 - 2 BLISTER PACK in 1 CARTON / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK / 100 uL in 1 VIAL, SINGLE-DOSE
- 82580-010 - Neffy
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 82580-010-02 identifies a specific commercial package of 2 blister pack in 1 carton / 1 vial, single-dose in 1 blister pack / 100 ul in 1 vial, single-dose of Neffy, a human prescription drug labeled by Ars Pharmaceuticals Operations, Inc.. This spray is formulated for nasal use and contains epinephrine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ars Pharmaceuticals Operations, Inc. on March 05, 2025. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. Epinephrine acts quickly to improve breathing, stimulate the heart, raise a dropping blood pressure, reverse hives, and reduce swelling of the face, lips, and throat.
How is this Ars Pharmaceuticals Operations, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 82580001002. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.